Welcome to our dedicated page for Mettler-Toledo news (Ticker: MTD), a resource for investors and traders seeking the latest updates and insights on Mettler-Toledo stock.
Mettler-Toledo International Inc. (MTD) delivers precision measurement solutions to laboratories, industries, and retailers worldwide. This news hub provides investors with essential updates about the company’s operational developments, financial performance, and technological innovations.
Access real-time press releases and curated analysis covering earnings announcements, product launches, strategic partnerships, and leadership updates. Our repository ensures you stay informed about MTD’s advancements in laboratory instrumentation, industrial weighing systems, and food retail technologies.
Key updates include quarterly financial results, regulatory filings, manufacturing expansions, and R&D breakthroughs in measurement science. Bookmark this page for direct access to MTD’s official communications and third-party analysis of market trends.
For stakeholders tracking precision instrumentation markets, this resource offers centralized monitoring of MTD’s global operations across 40+ countries. Return regularly for updates on how the company maintains leadership through innovation in pharma research support, industrial automation, and food safety compliance.
Mettler-Toledo International (NYSE:MTD) has announced the appointment of Pablo Perversi to its Board of Directors, effective November 6, 2025. Perversi, currently serving as President of Europe at Danone and a member of its Executive Committee, brings over 30 years of leadership experience in the food industry.
Prior to his current role, Perversi held key positions at Barry Callebaut as Chief Innovation, Quality, and Sustainability Officer and President of Gourmet Division (2017-2022), and various leadership roles at Unilever (1993-2017), including Vice President of Foods Europe. Board Chair Roland Diggelmann highlighted Perversi's extensive experience in the food industry, a crucial market for Mettler-Toledo.
Mettler-Toledo (NYSE:MTD) reported Q2 2025 results with reported sales increasing 4% to $983.2 million and local currency sales growing 2% year-over-year. The company achieved adjusted EPS of $10.09, up 5% from $9.65 in the prior year.
By region, local currency sales increased 3% in Americas, remained flat in Europe, and grew 3% in Asia/Rest of World. For full-year 2025, MTD expects local currency sales growth of 1-2% and adjusted EPS of $42.10-$42.60, representing 2-4% growth despite tariff headwinds.
The company reduced its estimated gross incremental tariff costs to $60 million annually, down from previous estimate of $115 million, with management implementing mitigation actions to largely offset the impact.
Mettler-Toledo International (NYSE:MTD), a leading global supplier of precision instruments and services, will release its Q2 2025 financial results on Thursday, July 31, 2025, after market close. The company will host a conference call to discuss the results on the following morning at 8:30 a.m. Eastern Time.
MTD maintains strong leadership positions across its businesses, with global number-one market positions in most segments. The company serves diverse industries including life sciences, food, and chemicals, offering critical solutions for R&D, quality control, and manufacturing processes. MTD operates in over 140 countries with direct presence in approximately 40 countries.
[]Mettler-Toledo International (NYSE:MTD) has announced its participation in the BofA Securities 2025 Healthcare Conference. The presentation is scheduled for Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time), with a live webcast available on the company's investor relations website.
Mettler-Toledo is a leading global supplier of precision instruments and services, claiming market leadership positions across most of its business segments. The company is recognized for innovation in R&D, quality control, and manufacturing processes, serving various industries including life sciences, food, and chemicals. Their products are distributed in over 140 countries, with direct presence in approximately 40 countries.
Mettler-Toledo International (NYSE: MTD) has scheduled its first quarter 2025 earnings release for Thursday, May 1, 2025, after market close. The company will host a conference call to discuss the results on Friday morning at 8:30 a.m. Eastern Time.
MTD is positioned as a leading global supplier of precision instruments and services, claiming market leadership in most of its business segments. The company serves various industries including life sciences, food, and chemicals, providing critical solutions for R&D, quality control, and manufacturing processes. MTD maintains an extensive sales and service network, operating in over 140 countries with direct presence in approximately 40 countries.
Mettler-Toledo (MTD) reported strong Q4 2024 results with reported and local currency sales increasing 12% year-over-year to $1.045 billion. Adjusted EPS reached $12.41, up 32% from $9.40 in the prior year. Regional sales growth showed increases of 6% in Americas, 18% in Europe, and 15% in Asia/Rest of World.
For full-year 2024, total reported sales increased 2% to $3.872 billion, with Adjusted EPS of $41.11, up 8% from $38.03 in 2023. The company's outlook for 2025 projects local currency sales growth of approximately 3%, with Adjusted EPS forecast between $42.35 to $43.00, representing 3-5% growth despite headwinds from shipping delays and adverse currency impacts.
Mettler-Toledo International (NYSE: MTD) has announced its upcoming fourth quarter 2024 earnings release, scheduled for Thursday, February 6, 2025, after market close. The company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results.
MTD is positioned as a leading global supplier of precision instruments and services, claiming global number-one market positions in most of its businesses. The company serves various industries including life sciences, food, and chemicals, providing critical solutions for R&D, quality control, and manufacturing processes. MTD maintains an extensive sales and service network, operating in more than 140 countries with direct presence in approximately 40 countries.
Mettler-Toledo International (NYSE: MTD) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Tuesday, January 14, 2025, at 3:45 p.m. Pacific Time, with a live webcast available on the company's investor relations website.
MTD is positioned as a leading global supplier of precision instruments and services, claiming market leadership in most of its business segments. The company is recognized for innovation in R&D, quality control, and manufacturing processes, serving various industries including life sciences, food, and chemicals. Their products are distributed across more than 140 countries, with direct presence in approximately 40 countries, supported by an extensive sales and service network.
Mettler-Toledo (MTD) reported Q3 2024 results with a 1% increase in both reported and local currency sales. Net earnings per diluted share (EPS) reached $9.96, up from $9.21 in the prior year, while adjusted EPS grew 4% to $10.21. Total reported sales rose to $954.5 million, with regional variations showing increases in Europe (2%) and Asia/Rest of World (4%), but a decline in the Americas (-1%). The Laboratory business and Service segment showed strong growth, though China faced challenging market conditions. For Q4 2024, the company expects local currency sales to increase approximately 8%, with adjusted EPS forecast between $11.63 to $11.78.
FAQ
What is the current stock price of Mettler-Toledo (MTD)?
What is the market cap of Mettler-Toledo (MTD)?
